Fomepizole

甲吡唑

Report date: 2023/11/01 20:08:59
NME

Base Information

Drug NameFomepizole
Drug Alias Name甲比唑fomepizol4-MethylpyrazolefomepizolumAntizol-Vet +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlcohol dehydrogenases inhibitors
TargetsAlcohol dehydrogenases
Therapy Area/IndicationsMethanol poisoningCorneal Dystrophies, Hereditary
Global Approved IndicationsMethanol poisoning
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/12/04
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaPending
Originator CompaniesPaladin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUtah State UniversityThe University Of ArizonaPar Pharmaceutical Inc +[4] 
Active IndicationsN/A
Inactive IndicationsMethanol poisoningCorneal Dystrophies, Hereditary

Other Information

ATC CodeV03AB34
Related LinksWikipediaDrugBankKEGG